COVID-19 ve Obezite: Sistematik Derleme

Year 2020, Volume: 8 Issue: 2, 506 - 514, 21.06.2020

Perihan Gürbüz

https://doi.org/10.33715/inonusaglik.735600

Cited By: 2

Abstract

Coronavirus 19 (COVID-19) pandemisi bugüne kadar dünyada 250.000'den fazla ölüme neden olmuştur. Neredeyse tüm ülkeler yaşama alışkanlıklarını radikal olarak etkileyen olağanüstü önlemler almış, pandemi sürecinde de ciddi ekonomik sorunlar ortaya çıkmıştır. Dünya, tedavi protokolü belirlenmesi ve aşı üretim çalışmalarına odaklanmıştır. Obezitenin, geçmiş iki koronavirüs endemisi dahil olmak üzere birçok akut ve kronik hastalık için önemli bir risk faktörü olduğu tespit edilmiştir. Bu çalışmada, COVID-19 ve obezite arasındaki ilişkiyi belirlemek için sistematik bir derleme planlanmıştır. Bu amaçla veritabanları araştırılmış ve 390 araştırma tespit edilmiştir. Bunlar arasından, kriterleri karşılayan 10 (on) araştırma çalışmaya dahil edilmiştir. Araştırmalar, hastaneye yatırılmış 6.073 COVID-19 hastası ile yapılmış olup aralarındaki obezite oranı (BMI ≥30)% 33-75.8 arasında değişmektedir. Obezite, hemen hemen tüm araştırmalarda COVID-19 hastalık süreci açısından bağımsız ve önemli bir risk faktörü olarak saptanmıştır. COVID-19 ve obezite ile ilgili daha ayrıntılı ve çok disiplinli araştırmalar, bilinmeyen ve öngörülemeyen COVID-19 salgını sürecinde değerli olacaktır.

Keywords

COVID-19, Obezite, Sistematik değerlendirme

COVID-19 AND OBESİTY: A SYSTEMATİC REVİEW

Abstract

Coronavirus 19 (COVID-19) pandemic has caused over than 250.000 deaths in world till date. Nearly all countries have taken extraordinary precautions that radically effect life styles, and also serious economical problems have become an important factor in the pandemic process. The world has focused on treatment protocol development and vaccine production studies. Including the two past coronavirus endemics, obesity has been detected to be an important risk factor for many of the acute and chronic diseases. In this study, a systematic review has been planned to determine the relationship between COVID-19 and obesity. For this aim, databases were searched and 390 researches have been determined. Among them 10 (ten) researches meeting criteria have been included in the study. The researches have been done with 6.073 hospitalized COVID-19 patients, and obesity ratio (BMI ≥30) among them differ between 33-75.8%. Obesity has been obtained to be an independent and important risk factor for COVID-19 process in nearly all researches. Further detailed multidisciplinary researches about COVID-19 and obesity will be valuable in the unknown and unpredictable COVID-19 pandemic process.

Keywords

COVID-19, Obesity, Systematic evaluation

References

• Center, J. H. U. a. M. C. R. (2020, 09.05.2020). COVID-19 Dashboard by CSSE.
• de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses, Nature Reviews Microbiology, 14(8), 523.
• Dhurandhar, N., Bailey, D., & Thomas, D. (2015). Interaction of obesity and infections, Obesity Reviews, 16(12), 1017-1029.
• Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013). Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis, Jama, 309(1), 71-82.
• Garg, S. (2020). Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020, MMWR. Morbidity and Mortality Weekly Report, 69.
• Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., . . . Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status, Military Medical Research, 7(1), 1-10.
• Gürbüz, P., Yetiş, G., & Çelikhan, G. (2016). Obezite ve yağ dokusu. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 4(2), 32-43.
• Gürbüz, P., Yetiş, G., Yakupoğulları, A., & Çelikcan, G. (2015). Çocukluk Çaği Obezitesi ve Metabolik Sendrom, İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 3(1), 9-13.
• Jose, R. J., & Manuel, A. (2020). Does COVID‐19 Disprove the Obesity Paradox in ARDS? Obesity.
• Kalligeros, M., Shehadeh, F., Mylona, E. K., Benitez, G., Beckwith, C. G., Chan, P. A., & Mylonakis, E. (2020). Association of Obesity with Disease Severity among Patients with COVID‐19, Obesity.
• Kass, D. A., Duggal, P., & Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. Lancet (London, England).
• Kruglikov, I. L., & Scherer, P. E. (2020). The role of adipocytes and adipocyte‐like cells in the severity of COVID‐19 infections, Obesity.
• Lemyze, M., Taufour, P., Duhamel, A., Temime, J., Nigeon, O., Vangrunderbeeck, N., . . . Thevenin, D. (2014). Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure, PloS one, 9(5).
• Lighter, J., Phillips, M., Hochman, S., Sterling, S., Johnson, D., Francois, F., & Stachel, A. (2020). Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission, Clin Infect Dis.
• Memtsoudis, S. G., Ivascu, N. S., Pryor, K. O., & Goldstein, P. A. (2020). Obesity as a risk factor for poor outcome in COVID-19 induced lung injury: the potential role of undiagnosed obstructive sleep apnoea, British Journal of Anaesthesia.
• Moser, J. A. S., Galindo‐Fraga, A., Ortiz‐Hernández, A. A., Gu, W., Hunsberger, S., Galán‐Herrera, J. F., . . . Group, L. R. I. S. (2019). Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses, Influenza and other respiratory viruses, 13(1), 3-9.
• Muscogiuri, G., Pugliese, G., Barrea, L., Savastano, S., & Colao, A. (2020). Obesity: the “Achilles heel” for COVID-19? Metabolism-Clinical and Experimental.
• Ni, Y.-N., Luo, J., Yu, H., Wang, Y.-W., Hu, Y.-H., Liu, D., . . . Liang, Z.-A. (2017). Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis, Critical Care, 21(1), 36.
• Nicholls, J., DONG, X. P., Jiang, G., & Peiris, M. (2003). SARS: clinical virology and pathogenesis, Respirology, 8, S6-S8.
• Öztürk, Z. A., Türkbeyler, İ. H., Abiyev, A., Kul, S., Edizer, B., Yakaryılmaz, F. D., & Soylu, G. (2018). Health‐related quality of life and fall risk associated with age‐related body composition changes; sarcopenia, obesity and sarcopenic obesity, Internal medicine journal, 48(8), 973-981.
• Peng, Y., Meng, K., Guan, H., Leng, L., Zhu, R., Wang, B., . . . Zeng, Q. (2020). Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV, Zhonghua xin xue guan bing za zhi, 48, E004-E004.
• Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O'Donnell, L. F., Chernyak, Y., . . . Horwitz, L. I. (2020). Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City, medRxiv.
• Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., . . . Jourdain, M. (2020). High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation, Obesity.
• Souza, G. M. C., Santos, G. M., Zimpel, S. A., & Melnik, T. (2020). Intraoperative ventilation strategies for obese patients undergoing bariatric surgery: systematic review and meta-analysis, BMC anesthesiology, 20(1), 36.
• Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020). Obesity and impaired metabolic health in patients with COVID-19, Nature Reviews Endocrinology, 1-2.
• Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis, Aging (Albany NY), 12(7), 6049. WHO. (2020). Obesity and Overweight. Retrieved 01.04.2020, from WHO https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• Zheng, K. I., Gao, F., Wang, X.-B., Sun, Q.-F., Pan, K.-H., Wang, T.-Y., . . . Zheng, M.-H. (2020). Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease, Metabolism, 154244.